HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 1.20
Day range
kr 1.18 - kr 1.21
Year range
kr 0.69 - kr 3.84
Market cap
133.45M SEK
Avg Volume
412.04K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | May 2025info | Y/Y change |
|---|---|---|
Revenue | 2.26M | -8.89% |
Operating expense | 10.50M | 19.50% |
Net income | -10.27M | -16.43% |
Net profit margin | -454.15 | -27.80% |
Earnings per share | — | — |
EBITDA | -9.74M | -9.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | May 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.71M | -19.65% |
Total assets | 52.21M | -14.59% |
Total liabilities | 11.12M | -21.17% |
Total equity | 41.09M | — |
Shares outstanding | 111.39M | — |
Price to book | 2.14 | — |
Return on assets | -45.54% | — |
Return on capital | -56.00% | — |
Cash Flow
Net change in cash
| (SEK) | May 2025info | Y/Y change |
|---|---|---|
Net income | -10.27M | -16.43% |
Cash from operations | -8.82M | 8.95% |
Cash from investing | -926.59K | — |
Cash from financing | 120.55K | 29.53% |
Net change in cash | -9.63M | -0.33% |
Free cash flow | -5.90M | 9.19% |
About
Founded
2014
Website
Employees
24
